Because it shares pharmacological features with licensed GLP-1 receptor agonists such as semaglutide and tirzepatide, clinically relevant interactions including with antidiabetic medicines, anticoagulants, and narrow therapeutic index drugs can be anticipated
While this molecule can be found in all human tissues, youll find some of the highest concentrations in the liver
S-allylcysteine prevents cisplatin-induced nephrotoxicity and oxidative stress
The results are real, the science is proven, and the support is hereright in your neighborhood
A 2023 observational study found that individuals on GLP-1 therapy lost an average of 1218 pounds within the first three months, even among those who made no formal diet changes
Losing weight reduces this pressure and alleviates pain